risk sharing

Research in Review

Varying Toxicities Between EGFR-TKIs for Treatment of NSCLC

12/29/2016

JCP Editors

Varying degrees of toxicity risks between different epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) can help inform treatment decisions for individual patients with non-small cell lung...

...

12/29/2016

Journal of Clinical Pathways

Research in Review

Proton Pump Inhibitors May Decrease Survival for Patients With Gastric Cancer

12/19/2016

JCP Editors

Over-the-counter heartburn and gastrointestinal drugs, such as proton pump inhibitors (PPIs), may decrease the effectiveness of chemotherapy in patients with gastroesophageal cancer (GEC), according to a new study...

...

12/19/2016

Journal of Clinical Pathways

Clinical Pathways GPS

The Role of Patient Adherence in Successful Clinical Pathway Implementation

02/16/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

When considering the development of clinical pathways, the pathway itself is only the beginning; optimum outcomes cannot be realized unless patients follow their prescribed treatments. Simply having prescribers write...

When...

02/16/2016

Journal of Clinical Pathways